FDA 483 - Revlon Group Holdings, LLC - January 12, 2024

Revlon Group Holdings, LLC in Oxford, NC, received a Form 483 following an FDA inspection from January 8-12, 2024. The inspection revealed significant deficiencies in equipment cleaning and sanitation, laboratory controls for water testing, and line clearance procedures, indicating potential cross-contamination and product quality issues in their OTC drug manufacturing.